期刊文献+

卵巢癌术后化疗的护理体会 被引量:1

下载PDF
导出
摘要 目的总结38例卵巢癌恶性肿瘤术后采用紫杉醇进行化疗的患者的护理经过,总结各种护理方法的临床意义。方法用紫杉醇治疗均采用TP方案,即紫杉醇+铂类联合化疗,8d为1疗程,间隔2周,一般需要6个疗程。总结出各种不同情况患者的不同特点,采取怎样的护理学方法,以及在执行护理时应当注意的要点及采取的措施。结果树立了患者战胜疾病的信心,降低了药物的毒性作用,减轻了患者的痛苦。结论护理人员有效、精心的护理及健康宣教可以提供卵巢癌患者的疗效及生活质量,延长生命。
作者 李晓玲
出处 《中国现代药物应用》 2010年第6期209-210,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献4

二级参考文献25

  • 1周际昌 韩锐.抗肿瘤药的毒副作用及处理.肿瘤化学预防及药物治疗[M].北京:北京医科大学中国协和医科大学联合出版社,1991.707-718.
  • 2张蕾.现代肿瘤热疗学原理、方法、临床[M].北京:学苑出版社,1997.32.
  • 3Sehouli J,Stengel D,Oskay G, et al.A new therapeutical approach:Topetecan plus gecitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy with paclitaxel and platinum.J Obstet Gynaecol Res,2003,29(3): 123-131.
  • 4Miller DS, Blessing JA, Lentz SS, et al.Phase lI evaluation of threeday topotecan in recurrent platinum-sensitive ovarian carcinoma: a gynecologic ontology group study. Cancer,2003,98(8): 1664-1669.
  • 5Rodriguez M, Rose G.Improved therapeutic index of lower dose topetecan chemotherapy in recurrent ovarian cancer. Gynecol Oncol,2001,83(2):257-262.
  • 6Denschlag D, Watermann D, Horig K, et al. Topotecan as a continu ous infusion over 14 days in recurrent ovarian cancer patients. Anticancer Res, 2004,24(2C): 1267-1269.
  • 7Goff BA, Thompson T, Greer BE, et al. Treatment of recurrent platinum resistant ovarian or peritoneal cancer with gemcitabine and doxorubicin: A phase I/II trial of the Puget Sound Ontology Consortium (PSOC 1602). Am J Obstet Gyneeol, 2003,188(6): 1556-1562.
  • 8D'Agostino G, Amant F, Berteloot P, et al. Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer.Gynecol Oncol, 2003,88(3):266-269.
  • 9Copeland L, Bookman M,Trimble E, et al. Clinical trials of newer regimens for treating ovarian cancer, the rationale for Gynecologic Ontology Group Protoeol GOG 182-ICONS.Gynecol Onco1,2003,90(2):S1-7.
  • 10The ICON and AGO Collaborators. Paclitaxel plus platinumbased chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2trial. Lancet, 2003,361 (9375): 2099-2106.

共引文献107

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部